IP Library Granted Patent US 8,195,296
Granted Patent B2
US 8,195,296 · App. 11/418,790 · Granted Jun 5, 2012

Apparatus for treating stress and urge incontinence

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,195,296
App. No.
11/418,790
Granted
Jun 5, 2012
Kind
B2
Abstract

Apparatus is provided, including an implantable mechanical support, shaped to support a portion of a urethra of a patient. One or more electrodes are coupled to the mechanical support, so as to contact tissue of the patient when the mechanical support is implanted in the patient. A control unit drives the electrodes to apply a current to the tissue. A method for treating a patient is also provided, including implanting a mechanical support in a position that supports a urethra of a patient. In response to increased pelvic pressure of the patient, a substance stored in a portion of the mechanical support that is not under the urethra is moved to a portion of the mechanical support that is under the urethra. Other embodiments are also described.

Claims (71)

1. A method, comprising:

providing an implantable member comprising mesh and at least one electrode;

making at least one incision in a patient;

implanting the member in contact with pelvic tissue of the patient comprising passing the implantable member through the at least one incision;

driving a current through the at least one electrode into the pelvic tissue of the patient; and

implanting a control unit in the patient comprising passing the control unit through the at least one incision, wherein driving a current through the at least one electrode comprises driving a current through the at least one electrode using the control unit.

2. The method according to claim 1 , wherein the mesh forms a sling.

3. The method according to claim 1 , comprising inducing relaxation of a pelvic muscle of the patient responsive to driving a current.

4. The method according to claim 1 , comprising treating a condition of the patient responsive to driving a current through the at least one electrode, wherein the condition of the patient is selected from the group consisting of: urge incontinence, bladder dysfunction, mixed incontinence, overactive bladder, interstitial cystitis, and fecal incontinence.

5. The method according to claim 1 , comprising treating incontinence of the patient responsive to driving a current through the at least one electrode.

6. The method of claim 5 , wherein treating incontinence of the patient responsive to driving a current through the at least one electrode comprises contracting the urinary sphincter of the patient.

7. The method according to claim 1 , comprising inducing relaxation of a bladder muscle of the patient without contracting a pelvic muscle of the patient responsive to driving a current through the at least one electrode.

8. The method according to claim 1 , comprising treating incontinence responsive to driving a current.

9. The method according to claim 8 , comprising generating a signal indicative of imminent incontinence of the patient.

10. The method of claim 1 , further comprising treating urge incontinence of the patient responsive to driving a current.

11. The method of claim 1 , wherein the at least one electrode is coupled to the mesh.

12. The method of claim 1 , further comprising mechanically supporting a pelvic structure of the patient using the mesh.

13. The method according to claim 12 , comprising treating incontinence responsive to mechanically supporting a pelvic structure of the patient using the mesh.

14. The method according to claim 12 , comprising treating cystocele responsive to mechanically supporting a pelvic structure of the patient using the mesh.

15. The method according to claim 12 , comprising treating pelvic organ prolapse responsive to mechanically supporting a pelvic structure of the patient using the mesh.

16. The method according to claim 12 , wherein mechanically supporting a pelvic structure of the patient comprises accessing the pelvic structure via an approach selected from the group consisting of: a suprapubic approach, a transvaginal approach, a retropubic approach, and a transobturator approach.

17. The method of claim 12 , wherein mechanically supporting comprises anchoring the member to structure of the patient other than the pelvic structure.

18. The method according to claim 12 , wherein:

mechanically supporting a pelvic structure of the patient comprises mechanically supporting a portion of the urethra of the patient with the mesh;

the at least one electrode comprises a plurality of electrodes; and

driving a current comprises driving the current from the plurality of electrodes which are aligned around less than 180 degrees of the urethra.

19. The method according to claim 18 , comprising:

at a pre-implantation time prior to a first time of mechanically supporting the portion of the urethra, identifying the patient as not suffering from urge incontinence; and at a post-implantation time subsequent to the first time of mechanically supporting the portion of the urethra, identifying the patient as suffering from urge incontinence, wherein driving the current comprises:

not driving the current on each of any 30 consecutive days prior to the post-implantation time; and

driving the current on each of at least 30 consecutive days following the post-implantation time.

20. The method according to claim 18 , wherein driving a current comprises starting to drive a current on each of at least 30 consecutive days at a time greater than 60 days from a first time of mechanically supporting the portion of the urethra.

21. The method according to claim 20 , comprising treating at least one condition responsive to driving a current, wherein the at least one condition including a condition that is not stress incontinence.

22. A method, comprising:

providing an implantable member comprising mesh and a plurality of electrodes;

making at least one incision in a patient;

implanting the member in contact with pelvic tissue of the patient comprising passing the implantable member through the at least one incision;

mechanically supporting a pelvic structure of the patient using the mesh comprising mechanically supporting a portion of the urethra of the patient with the mesh, wherein the electrodes are aligned around less than 180 degrees of the urethra; and

driving a current through at least one of the plurality of electrodes into the pelvic tissue of the patient, comprising starting to drive a current on each of at least 30 consecutive days at a time greater than 60 days from a first time of mechanically supporting the portion of the urethra.

23. The method according to claim 22 , comprising treating at least one condition responsive to driving a current, wherein the at least one condition including a condition that is not stress incontinence.

24. The method according to claim 22 , comprising treating incontinence responsive to mechanically supporting a pelvic structure of the patient using the mesh.

25. The method according to claim 22 , comprising treating cystocele responsive to mechanically supporting a pelvic structure of the patient using the mesh.

26. The method according to claim 22 , comprising treating pelvic organ prolapse responsive to mechanically supporting a pelvic structure of the patient using the mesh.

27. The method according to claim 22 , wherein the mesh forms a sling.

28. The method according to claim 22 , wherein mechanically supporting a pelvic structure of the patient comprises accessing the pelvic structure via an approach selected from the group consisting of: a suprapubic approach, a transvaginal approach, a retropubic approach, and a transobturator approach.

29. The method according to claim 22 , comprising inducing relaxation of a pelvic muscle of the patient responsive to driving a current.

30. The method according to claim 22 , comprising treating a condition of the patient responsive to driving a current, wherein the condition of the patient is selected from the group consisting of: urge incontinence, bladder dysfunction, mixed incontinence, overactive bladder, interstitial cystitis, and fecal incontinence.

31. The method according to claim 22 , comprising treating incontinence of the patient responsive to driving a current through the at least one electrode.

32. The method according to claim 22 , comprising inducing relaxation of a bladder muscle of the patient without contracting a pelvic muscle of the patient responsive to driving a current.

33. The method according to claim 22 , comprising implanting a control unit in the patient comprising passing the control unit through the at least one incision, wherein driving a current through at least one of the plurality of electrode comprises driving a current through at least one of the plurality of electrodes using the control unit.

34. A method, comprising:

providing an implantable member comprising mesh and a plurality of electrodes;

making at least one incision in a patient;

implanting the member in contact with pelvic tissue of the patient comprising passing the implantable member through the at least one incision;

mechanically supporting a pelvic structure of the patient using the mesh comprising mechanically supporting a portion of the urethra of the patient with the mesh, wherein the electrodes are aligned around less than 180 degrees of the urethra; and

driving a current through at least one of the plurality of electrodes into the pelvic tissue of the patient;

wherein:

at a pre-implantation time prior to a first time of mechanically supporting the portion of the urethra, identifying the patient as not suffering from urge incontinence; and

at a post-implantation time subsequent to the first time of mechanically supporting the portion of the urethra, identifying the patient as suffering from urge incontinence, wherein driving the current comprises:

not driving the current on each of any 30 consecutive days prior to the post-implantation time; and

driving the current on each of at least 30 consecutive days following the post-implantation time.

35. The method according to claim 34 , comprising treating at least one condition responsive to driving a current, wherein the at least one condition including a condition that is not stress incontinence.

36. The method according to claim 34 , comprising treating incontinence responsive to mechanically supporting a pelvic structure of the patient using the mesh.

37. The method according to claim 34 , comprising treating cystocele responsive to mechanically supporting a pelvic structure of the patient using the mesh.

38. The method according to claim 34 , comprising treating pelvic organ prolapse responsive to mechanically supporting a pelvic structure of the patient using the mesh.

39. The method according to claim 34 , wherein the mesh forms a sling.

40. The method according to claim 34 , wherein mechanically supporting a pelvic structure of the patient comprises accessing the pelvic structure via an approach selected from the group consisting of: a suprapubic approach, a transvaginal approach, a retropubic approach, and a transobturator approach.

41. The method according to claim 34 , comprising inducing relaxation of a pelvic muscle of the patient responsive to driving a current.

42. The method according to claim 34 , comprising treating a condition of the patient responsive to driving a current, wherein the condition of the patient is selected from the group consisting of: urge incontinence, bladder dysfunction, mixed incontinence, overactive bladder, interstitial cystitis, and fecal incontinence.

43. The method according to claim 34 , comprising treating incontinence of the patient responsive to driving a current through the at least one electrode.

44. The method according to claim 34 , comprising inducing relaxation of a bladder muscle of the patient without contracting a pelvic muscle of the patient responsive to driving a current.

45. The method according to claim 34 , comprising implanting a control unit in the patient comprising passing the control unit through the at least one incision, wherein driving a current through at least one of the plurality of electrode comprises driving a current through at least one of the plurality of electrodes using the control unit.

Assignments (18)
SECURITY INTEREST Recorded Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →
SECURITY INTEREST Recorded Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2024
From: ENDO USA, INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067245/0492 →
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0491 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2024
From: ASTORA WOMEN’S HEALTH, LLC
To: ENDO USA, INC.
Reel/Frame 067202/0768 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0607. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 11, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037514/0402 →
CHANGE OF NAME Recorded Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0425 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0607 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
SECURITY AGREEMENT Recorded Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 11, 2008
From: LONGHINI, ROSS A.
To: AMS RESEARCH CORPORATION
Reel/Frame 021224/0487 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2006
From: GROSS, YOSEF, DR.
To: AMS RESEARCH CORPORATION
Reel/Frame 018514/0566 →